See also this year's filing and all EDGAR filings for this company.
PDF Report 0001868912_2024_Enfusion_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001868912')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001868912, Enfusion Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesCurrent | 20,309,000 |
| 1 | LongTermDebt | 11,181,000 |
| 2 | remainder_Liabilities | 0 |
| 3 | IntangibleAssets | 14,304,000 |
| 4 | AssetsNoncurrent | 6,502,000 |
| 5 | AssetsCurrent | 69,852,000 |
| 6 | PropertyPlantAndEquipmentNet | 18,314,000 |
| 7 | remainder_Assets | 0 |
| 8 | SellingAndMarketingExpense | 20,418,000 |
| 9 | GeneralAndAdministrativeExpense | 64,635,000 |
| 10 | ResearchAndDevelopmentExpense | 0 |
| 11 | remainder_Expenses | 79,765,000 |
| 12 | remainder_Revenues | 174,535,000 |
| 13 | remainder_NetIncome | -464,000 |
| 14 | remainder_ComprehensiveNetIncome | -3,130,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 31,490,000 |
| 1 | Assets | 108,972,000 |
| 2 | Expenses | 164,818,000 |
| 3 | Revenues | 174,535,000 |
| 4 | StockholdersEquity | 77,482,000 |
| 5 | NetIncome | 9,253,000 |
| 6 | ComprehensiveNetIncome | 6,123,000 |
| 7 | BaseVar | 241,704,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.73 |
| 9 | EconomicCapitalRatio | 5.03 |